Pre-Operative MRI Effective in Women with Dense Breasts
|
By HospiMedica International staff writers Posted on 11 Nov 2020 |
Pre-operative MRI can catch more breast cancer lesions in women with dense breasts who receive an initial diagnosis via digital breast tomosynthesis (DBT), according to a new study.
Researchers at the University of Pennsylvania (Penn; Philadelphia, USA) conducted a retrospective study of 388 preoperative MRI exams for newly detected breast cancer identified either by digital mammography (DM) or DBT, in order to assess the role of MRI in assessment of tumor extent. MRI detection of occult disease was stratified by modality, breast density, and background parenchymal enhancement. A true-positive finding was defined as malignancy in the ipsilateral-breast at least two cm away from the index-lesion, or in the contralateral breast.
The results revealed 50 additional malignancies (12.9%), 37 of them ipsilateral and 13 contralateral. But while in DM there was no significant difference in the rate of MRI additional cancer detection in dense breasts, in those who underwent DBT, significantly more additional sites of malignancy were detected. In addition, in both DM and DBT cohorts, higher background parenchymal enhancement was associated with higher false-positive rates, but no significant difference was found in true-positive exams. The study was published on October 13, 2020, in Clinical Imaging.
“We found a trend of increasing detection by MRI of additional sites of malignancies in patients with dense breasts compared to those with non-dense breasts, irrespective of initial imaging modality,” said senior author Elizabeth McDonald, MD, PhD. “These findings suggest that in women imaged with DBT, MRI may have less value for determining extent of disease than in women with non-dense breasts. Women with dense breasts appear to benefit more from pre-operative MRI than non-dense women.”
Breast density is a measurement of the amount of fatty tissue versus the amount of fibrous tissue in the breast. Because both cancer and dense tissue appear white on a mammogram, tumors often remain masked, resulting in almost one third of cancerous tumors in dense breasts being masked by the tissue during X-ray mammography. According to a 2014 report published by the Journal of the U.S. National Cancer Institute, an estimated 43.3% of women between the ages of 40 and 74 years old have extremely dense breast tissue.
Related Links:
University of Pennsylvania
Researchers at the University of Pennsylvania (Penn; Philadelphia, USA) conducted a retrospective study of 388 preoperative MRI exams for newly detected breast cancer identified either by digital mammography (DM) or DBT, in order to assess the role of MRI in assessment of tumor extent. MRI detection of occult disease was stratified by modality, breast density, and background parenchymal enhancement. A true-positive finding was defined as malignancy in the ipsilateral-breast at least two cm away from the index-lesion, or in the contralateral breast.
The results revealed 50 additional malignancies (12.9%), 37 of them ipsilateral and 13 contralateral. But while in DM there was no significant difference in the rate of MRI additional cancer detection in dense breasts, in those who underwent DBT, significantly more additional sites of malignancy were detected. In addition, in both DM and DBT cohorts, higher background parenchymal enhancement was associated with higher false-positive rates, but no significant difference was found in true-positive exams. The study was published on October 13, 2020, in Clinical Imaging.
“We found a trend of increasing detection by MRI of additional sites of malignancies in patients with dense breasts compared to those with non-dense breasts, irrespective of initial imaging modality,” said senior author Elizabeth McDonald, MD, PhD. “These findings suggest that in women imaged with DBT, MRI may have less value for determining extent of disease than in women with non-dense breasts. Women with dense breasts appear to benefit more from pre-operative MRI than non-dense women.”
Breast density is a measurement of the amount of fatty tissue versus the amount of fibrous tissue in the breast. Because both cancer and dense tissue appear white on a mammogram, tumors often remain masked, resulting in almost one third of cancerous tumors in dense breasts being masked by the tissue during X-ray mammography. According to a 2014 report published by the Journal of the U.S. National Cancer Institute, an estimated 43.3% of women between the ages of 40 and 74 years old have extremely dense breast tissue.
Related Links:
University of Pennsylvania
Latest MRI News
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read moreCritical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read moreSurgical Techniques
view channel
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read more
New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
Volumetric muscle loss is a traumatic loss of skeletal muscle that often leads to permanent functional impairment and limited reconstructive options. Current experimental strategies struggle to deliver... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







